Adenosine Kinase Inhibition Selectively Promotes Rodent and Porcine Islet β-cell Replication
Overview
Authors
Affiliations
Diabetes is a pathological condition characterized by relative insulin deficiency, persistent hyperglycemia, and, consequently, diffuse micro- and macrovascular disease. One therapeutic strategy is to amplify insulin-secretion capacity by increasing the number of the insulin-producing β cells without triggering a generalized proliferative response. Here, we present the development of a small-molecule screening platform for the identification of molecules that increase β-cell replication. Using this platform, we identify a class of compounds [adenosine kinase inhibitors (ADK-Is)] that promote replication of primary β cells in three species (mouse, rat, and pig). Furthermore, the replication effect of ADK-Is is cell type-selective: treatment of islet cell cultures with ADK-Is increases replication of β cells but not that of α cells, PP cells, or fibroblasts. Short-term in vivo treatment with an ADK-I also increases β-cell replication but not exocrine cell or hepatocyte replication. Therefore, we propose ADK inhibition as a strategy for the treatment of diabetes.
Mechanistic insights and approaches for beta cell regeneration.
Karampelias C, Liu K, Tengholm A, Andersson O Nat Chem Biol. 2025; .
PMID: 39881214 DOI: 10.1038/s41589-024-01822-y.
Zeng X, Wang Y, Farias K, Rappa A, Darko C, Sauve A Metabolism. 2024; 164:156110.
PMID: 39710001 PMC: 11788054. DOI: 10.1016/j.metabol.2024.156110.
Inactivation of HIPK2 attenuates KRAS activity and prevents pancreatic tumorigenesis.
Sozzi S, Manni I, Ercolani C, Diodoro M, Bartolazzi A, Spallotta F J Exp Clin Cancer Res. 2024; 43(1):265.
PMID: 39342278 PMC: 11437985. DOI: 10.1186/s13046-024-03189-3.
Developmental and foliation changes due to dysregulation of adenosine kinase in the cerebellum.
Gebril H, Lai T, Fedele D, Wahba A Sci Rep. 2023; 13(1):19831.
PMID: 37963945 PMC: 10645999. DOI: 10.1038/s41598-023-47098-5.
Goode R, Hum J, Kalwat M Endocrinology. 2022; 164(1).
PMID: 36412119 PMC: 9923807. DOI: 10.1210/endocr/bqac193.